December 21, 1994
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, DC 20549-1004
Re: Commission File No.: 0-2085
---------------------------------
Dear Sirs:
In compliance with Item 601(c) of Regulation S-K and Rule 401 of
Regulation S-T, Betz Laboratories, Inc. ("Company") hereby submits for
filing with the Commission its Financial Data Schedule under cover of
Amendment Number 1 to its Form 10-Q for the quarter ended September 30,
1994.
Very truly yours,
BETZ LABORATORIES, INC.
James H. Decker
Assistant General Counsel
<PAGE>
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-------------------------------------
AMENDMENT NUMBER 1 TO
QUARTERLY REPORT UNDER SECTION 13
OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
------------------------------------
For Quarter Ended September 30, 1994
-----------------------
Commission File Number: 0-2085
--------
BETZ LABORATORIES, INC.
---------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 23-1503731
- -------------------------------- --------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
4636 Somerton Road, Trevose, PA 19053
- ----------------------------------------- --------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (215) 355-3300
--------------
Indicate by check mark whether the registrant (1) has filed all re-
ports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such report(s), and (2) has
been subject to such filing requirements for the past 90 days.
Yes X No
------- ------
Indicate the number of shares outstanding of each of the issuer's
classes of common stock as of the latest practicable date.
27,823,655 Common Shares outstanding as of November 4, 1994.
----------- ----------------
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
BETZ LABORATORIES, INC.
------------------------
(Registrant)
Date: December 21, 1994 By: s/R. Dale Voncanon
------------------------------
R. Dale Voncanon
Vice President - Finance
Date: December 21, 1994 By: s/William C. Brafford
------------------------------
William C. Brafford
Vice President,
Secretary and General Counsel
[LEGEND]
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1994
<PERIOD-END> SEP-30-1994
<CASH> 44,022
<SECURITIES> 0
<RECEIVABLES> 120,308
<ALLOWANCES> 3,286
<INVENTORY> 41,740
<CURRENT-ASSETS> 232,700
<PP&E> 585,669
<DEPRECIATION> 283,287
<TOTAL-ASSETS> 546,618
<CURRENT-LIABILITIES> 108,745
<BONDS> 96,500
5,471
0
<COMMON> 3,365
<OTHER-SE> 301,733
<TOTAL-LIABILITY-AND-EQUITY> 546,618
<SALES> 533,033
<TOTAL-REVENUES> 533,033
<CGS> 188,980
<TOTAL-COSTS> 188,980
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 182
<INCOME-PRETAX> 94,106
<INCOME-TAX> 37,324
<INCOME-CONTINUING> 56,782
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 56,782
<EPS-PRIMARY> 1.90
<EPS-DILUTED> 1.79
</TABLE>
